MIR5094: A Potential Drug Target and Biomarker (G100847059)

Target Name: MIR5094

NCBI ID: G100847059

Other Name(s): MicroRNA 5094 | hsa-mir-5094 | hsa-miR-5094 | microRNA 5094

MIR5094: A Potential Drug Target and Biomarker

MIR5094 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research on its potential clinical applications.

MIR5094 is a small non-coding RNA molecule that is typically expressed in a very low level in the body. It is made up of 229 amino acid residues and has a calculated molecular weight of 31 kDa. MIR5094 is highly conserved across various species, which suggests that it is a highly conserved protein that has been preserved over time.

One of the key features of MIR5094 is its nuclear localization. MIR5094 is primarily expressed in the nucleus of the cell and is highly enriched in the nuclear fraction of the cell compared to the cytoplasm. This is consistent with the idea that MIR5094 is involved in gene expression and cell signaling.

Another feature of MIR5094 is its interaction with DNA. MIR5094 has been shown to interact with the transcription factor, p53, which is a well-known regulator of gene expression and cell signaling. This interaction between MIR5094 and p53 suggests that MIR5094 may be involved in the regulation of p53-mediated gene expression.

In addition to its nuclear localization and interaction with p53, MIR5094 has also been shown to play a role in the regulation of cellular processes that are important for cancer progression. For example, MIR5094 has been shown to be involved in the regulation of cell adhesion, which is a critical process for the development of cancer stem cells.

MIR5094 has also been shown to play a role in the regulation of cellular signaling pathways that are important for cancer progression. For example, MIR5094 has been shown to be involved in the regulation of the PI3K/AKT signaling pathway, which is a critical pathway for cell signaling and growth.

In conclusion, MIR5094 is a promising drug target and biomarker for various diseases, including cancer. Its unique structure and function, as well as its nuclear localization and interaction with important transcription factors, make it an attractive target for researchers to study. Further research is needed to fully understand the role of MIR5094 in disease progression and to develop safe and effective treatments.

Protein Name: MicroRNA 5094

More Common Targets